Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · IEX Real-Time Price · USD
17.02
-0.64 (-3.62%)
May 20, 2022 4:00 PM EDT - Market closed
Ratios and Metrics (Trailing)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Period Ended | Current | 2022-03-31 | 2021-12-31 |
|---|---|---|---|
| Market Capitalization | 498 | 643 | 496 |
| Enterprise Value | 366 | 510 | 348 |
| PE Ratio | - | - | -10.74 |
| PB Ratio | 3.53 | 4.56 | 3.26 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 |
| Debt / EBITDA Ratio | - | - | -0.03 |
| Debt / FCF Ratio | - | - | -0.03 |
| Current Ratio | 27.90 | 27.90 | 21.14 |
| Return on Equity (ROE) | - | - | -211.90% |
| Return on Assets (ROA) | - | - | -50.70% |
| Return on Capital (ROIC) | - | - | -1055.70% |
| Earnings Yield | -10.20% | - | -9.31% |
| FCF Yield | - | - | -6.96% |
| Buyback Yield / Dilution | - | - | -1305.21% |
| Total Shareholder Return | - | 0.00% | -1305.21% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).